Written by: Lisa Newey-Keane
Our key driver at Malvern Instruments is to create technologies that make a difference or solve a problem, and working hand-in-hand
with our customers enables us to make sure that’s exactly what’s happening, out in the field. We place a high value on our collaborations
and partnerships with customers from a wide range of industries and organizations across the globe and love to see how our systems
are being used in real-world scenarios. This gives us vital feedback on what we’re doing well, and also any tweaks we need to make in
order to optimize our technologies.
One of our closest collaborations is with John Carpenter, Professor of Pharmaceutical Sciences at the University of Colorado, Anschutz Medical Campus. John’s laboratory works on understanding and finding ways of controlling aggregates and other particles in biopharmaceutical products which may affect product quality, efficacy, and even safety. As investment in the development and manufacture of protein-based therapeutics continues to surge worldwide, it is vital that this is supported by efforts to further understanding and optimization of their biophysical properties. John’s team aims to evaluate new analytical technologies – including those developed by Malvern Instruments – that can offer insight in this area.
Within the Carpenter lab, there is currently a range of Malvern technologies, including NanoSight, MicroCal, Morphologi, Archimedes and Viscotek instruments, which have together enabled the team to make significant advances in characterizing particles, especially those in the subvisible range, in protein drug delivery systems. One of the challenges, and also the success stories, of this collaboration has been the group’s growing understanding of how to use these techniques together, in a complementary and sometimes orthogonal way, to develop a full biophysical picture of a product.
“We have been fortunate to have a long-term collaboration with Malvern Instruments, in which we work together on the applications of state-of-the-art instruments and also the development of guidance for best practice for the characterization of therapeutic protein samples. We benefit from this relationship, not only because of access to the newest and best instruments, but also because of the expert guidance and advice we receive from our Malvern collaborators. And we have a lot of fun working together!”
John Carpenter, Professor of Pharmaceutical Sciences in the Department of Pharmaceutical Sciences at the University of Colorado, Anschutz Medical Campus